ARID1A and colorectal cancer: Specifically, we surveyed the genes most strongly reduced by ARID1B KD in ARID1A-/- cells and identified MET, a known driver of proliferation, as a potentially crucial target of ARID1A and ARID1B in colorectal cancer.